Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinumYOON, D. H; RYU, M.-H; PARK, Y. S et al.British journal of cancer. 2012, Vol 106, Num 6, pp 1039-1044, issn 0007-0920, 6 p.Article

Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)KANG, Y.-K; CHANG, H.-M; PARK, Y. S et al.British journal of cancer. 2013, Vol 108, Num 6, pp 1245-1251, issn 0007-0920, 7 p.Article

Effect of rebamipide on the glycosaminoglycan content of the ulcerated rat stomachSONG, D.-U; RYU, M.-H; CHAY, K.-O et al.Fundamental & clinical pharmacology. 1998, Vol 12, Num 5, pp 546-552, issn 0767-3981Article

Phase II study of S-I combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activityKIM, K-P; JANG, G; CHANG, H.-M et al.British journal of cancer. 2011, Vol 104, Num 4, pp 605-612, issn 0007-0920, 8 p.Article

A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancerKANG, H. J; CHANG, H. M; KIM, T. W et al.British journal of cancer. 2008, Vol 98, Num 2, pp 316-322, issn 0007-0920, 7 p.Article

A randomised multicentre phase II trial of capecitabine vs S-I as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancerLEE, J.-L; KANG, Y.-K; RYU, M.-H et al.British journal of cancer. 2008, Vol 99, Num 4, pp 584-590, issn 0007-0920, 7 p.Article

Semiconductor switches based pulse power generator for plasma source ion implantationKIM, J. H; RYU, M. H; SHENDEREY, S et al.IEEE international power modulator conference. 2004, pp 378-382, isbn 0-7803-8586-1, 1Vol, 5 p.Conference Paper

Phase ii study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapyKANG, H. J; CHANG, H. M; KIM, T. W et al.British journal of cancer. 2005, Vol 92, Num 2, pp 246-251, issn 0007-0920, 6 p.Article

Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancerKIM, T. W; CHANG, H. M; KANG, H. J et al.Annals of oncology. 2003, Vol 14, Num 7, pp 1115-1120, issn 0923-7534, 6 p.Article